18F-Fluciclovine Uptake in Intramuscular Injecting Site of Antiandrogen.

Te-Chun Hsieh, Yu-Chin Wu, Chia-Hung Kao, Kuo-Yang Yen, Shung-Shung Sun

Clinical nuclear medicine 2022 May 01

filter terms:

18F-fluciclovine, a radiolabeled amino acid analog, has been approved by US Food and Drug Administration for detecting lesions of biochemical recurrence of prostate adenocarcinoma with PET/CT. However, it is not specific for prostate cancer and has been found to be present in variety of malignant and benign etiologies. We herein present an interesting case of the incidental finding of increasing uptake of 18F-fluciclovine related to intramuscular injection of antiandrogen. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Citation

Te-Chun Hsieh, Yu-Chin Wu, Chia-Hung Kao, Kuo-Yang Yen, Shung-Shung Sun. 18F-Fluciclovine Uptake in Intramuscular Injecting Site of Antiandrogen. Clinical nuclear medicine. 2022 May 01;47(5):e401-e402